• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

283.54 -2.47 (-0.86%)
Official Closing Price Updated: 4:10 PM EST, Nov 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,977,663
Open 285.00
Bid (Size) 282.80 (40)
Ask (Size) 283.54 (680)
Prev. Close 286.01
Today's Range 279.88 - 286.05
52wk Range 190.75 - 302.93
Shares Outstanding N/A
Dividend Yield 2.44%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
These 3 Dividend Stocks Have Crushed the Market This Year. Here’s Why They Are Still Buys ↗
November 16, 2026
They have excellent long-term prospects. 
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy? ↗
November 14, 2026
These healthcare dividend stocks appeal to investors in different ways. 
Via The Motley Fool
Topics Earnings Intellectual Property

Performance

52-Week Range 6.4% below 52-week high
283.54
190.7552W Low 302.9352W High
1 Week 5.9% below 1-week high
284.911W Low 301.201W High

AbbVie (ABBV) traded between $190.75 and $302.93 over the past 52 weeks and last traded at $283.54, 6.4% below its 52-week high. Over the past week it ranged between $284.91 and $301.20.

Past 12 Months
-3.7%
+0.3%
+6.6%
+33.6%
+23.6%
+21.2%
1W -$10.91
1M +$0.86
3M +$17.57
6M +$71.24
YTD +$54.23
1Y +$49.67

ABBV was +21.2% over the past year, +33.6% over six months, +23.6% year to date, -3.7% in the last week.

12 Months vs Market
ABBV
+21.2%
DIA
+6.4%
SPY
+8.5%
QQQ
+8.2%
IWM
+13.2%

Over the past 12 months ABBV returned +21.2% versus DIA (Dow) +6.4%, SPY (S&P 500) +8.5%, QQQ (Nasdaq 100) +8.2% and IWM (Russell 2000) +13.2%.

Volume & Liquidity 1.04× 3-mo avg
Today 4,977,663 3-mo avg 4.8M
1W
4.3M
1M
5.1M
3M
4.8M
6M
5.7M
YTD
6.3M
1Y
6.2M

ABBV most recently traded 4,977,663 shares against a 3-month average daily volume of 4.8M.

More News

Read More
News headline image
3 Dividend Stocks Built for a Market Priced Like It's 1999 ↗
November 13, 2026
Via The Motley Fool
Topics Artificial Intelligence
AbbVie (NYSE:ABBV): A Quality Investing Candidate With Caveats ↗
November 03, 2026
Via Chartmill
AbbVie (NYSE:ABBV) Q3 2026 Results In Line With Estimates as Guidance and Dividend Rise ↗
October 30, 2026
Via Chartmill
News headline image
Nvidia CEO Jensen Huang Says AI's 'Most Profound Impact' Will Be in Life Sciences -- and Eli Lilly Is Already Building on It ↗
November 12, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
3 Pharmaceutical Stocks That Offer Safety and Growth ↗
November 12, 2026
Via MarketBeat
Topics Artificial Intelligence Economy
News headline image
Stock Market Sell-Off: Meet the Unstoppable Vanguard ETF Obliterating the S&P 500 in 2026 ↗
November 10, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
MarketBeat Week in Review – 11/2 - 11/6 ↗
November 07, 2026
Via MarketBeat
News headline image
2 unpopular stocks that deserve some love and 1 facing challenges
November 05, 2026
Via StockStory
News headline image
3 Dividend Kings to Buy in November and Never Sell ↗
November 05, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Growth Stocks to Buy in November Without Any Hesitation ↗
November 05, 2026
Via The Motley Fool
Juvederm vs Other Dermal Fillers: What Makes It Different and Who It Is For
November 04, 2026
Via BusinesNews Wire
News headline image
AbbVie's Humira Era Is Fading, But Its New Growth Engines Face Another Test ↗
November 02, 2026
Via MarketBeat
Topics Intellectual Property
News headline image
The Best Dividend Stocks to Buy With $5,000 in November ↗
November 02, 2026
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy for 2027? ↗
November 02, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Prediction: AbbVie's Next Blockbuster Is Hiding in a Two-Drug Crohn's Combo ↗
November 02, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
The top 5 analyst questions from AbbVie’s Q3 earnings call
November 01, 2026
Via StockStory
Topics Earnings
News headline image
AbbVie: 3 Key Takeaways for Long-Term Investors ↗
October 31, 2026
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
Is AbbVie a Buy After Its Latest Earnings Report? ↗
October 31, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
ABBV Q3 deep dive: Immunology and neuroscience drive growth, pipeline progress continues
October 31, 2026
Via StockStory
News headline image
AbbVie (ABBV) Q3 2026 Earnings Call Transcript ↗
October 30, 2026
Via The Motley Fool
Topics Earnings
News headline image
What AbbVie (ABBV) Said on Its Q3 Earnings Call ↗
October 30, 2026
Via MarketBeat
Topics Earnings
News headline image
AbbVie (NYSE:ABBV) posts Q3 2026 sales in line with estimates
October 30, 2026
Via StockStory
News headline image
AbbVie (ABBV) reports earnings tomorrow: what to expect
October 29, 2026
Via StockStory
Topics Artificial Intelligence

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 283.54
When was AbbVie last traded?
The last trade of AbbVie was at 11/19/26 04:10 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap